Skip to main content
Premium Trial:

Request an Annual Quote

LGC Genomics Gains Illumina CSPro Certification

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – LGC Genomics today announced it has received Illumina CSPro certification for sequencing.

Illumina CSPro is a collaborative certified service provider partnership "dedicated to ensure the delivery of the highest quality data available for genetic analysis applications," LGC said in a statement.

Today's certification makes LGC CSPro-certified in Berlin, where it can use Illumina technology to provide sequencing services. The company also has an office in the UK.

LGC completed a two-phase certification process, which included minimum data generation, data certification, and an on-site audit of the facility and processes, it said.

LGC Genomics is a division of LGC, which last month announced the purchase of KBioscience, which was then combined with LGC Genomics.

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.